Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: RTOG 0534 A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY

 


RTOG 0534 A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY


Trial Focus

Prostate Cancer

Objective

         The purpose of this study is to compare the effects, good and/or bad of three treatment methods on participants and their cancer.

IRB Protocol #

08-1383

Trial Status

Archived

Principle Investigator

BRIAN KAVANAGH

Sponsor

RTOG

Contact

MONICA ROBISCHON at (720) 848-0661 or MONICA.ROBISCHON@UCDENVER.EDU

Location

ST. MARYS HOSPITAL - G.J. University of Colorado Hospital ST. MARYS HOSPITAL - G.J. University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : Patients will receive 36-39 radiation treatments over 7-8 weeks. Hormone therapy, if given, will last 4-6 months. Follow-up exams will occur every 3 months for the first year, then every 6 months for the next 4 years. After that, the study doctors would like to keep track of patients' medical condition every year for life. // Eligibility criteria include but are not limited to 18 years or older at high risk for recurrence of prostate cancer.Eligibility criteria include but are not limited to 18 years or older at high risk for recurrence of prostate cancer.